Home › Targets › RAS(ON)

RAS(ON) (1 companies · 2 programs)

Companies with an active program directed at RAS(ON).

Revolution Medicines, Inc. RVMD

RASONQUE — Pancreatic Ductal Adenocarcinoma Approved
RASONQUE — Non-Small Cell Lung Cancer NDA Submitted